This page includes the latest FDA filings for Altathera Pharmaceuticals L L C. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2023-10-06 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2023-08-21 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2023-07-27 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2023-05-29 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2022-01-14 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2020-11-22 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2020-03-18 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2019-12-07 |
ALTATHERA Pharmaceuticals, LLC, Mylan Institutional | Prescription Medication | 2016-02-26 |
ALTATHERA Pharmaceuticals, LLC | Sotalol Hydrochloride | 2015-10-15 |
NCAGE Code | 7FYJ8 | ALTATHERA PHARMACEUTICALS LLC |
CAGE Code | 7FYJ8 | ALTATHERA PHARMACEUTICALS LLC |
S.A.M. Registration | 7FYJ8 [53682098] | ALTATHERA PHARMACEUTICALS LLC |
SEC | 0001604121 | AltaThera Pharmaceuticals, LLC of IL |